InvestorsHub Logo
Followers 3
Posts 789
Boards Moderated 0
Alias Born 01/10/2010

Re: None

Friday, 02/17/2012 9:19:20 AM

Friday, February 17, 2012 9:19:20 AM

Post# of 6305
“We expect that our technology will change the standard care for spinal cord injury treatment. We’re currently under review at FDA and we look forward to receiving approval to begin human studies,”

“Our therapeutic approach confirms a clear paradigm shift in the treatment of spinal cord injuries.”

sounds good to me...